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Abstract: The title compound was prepared by electrophilic aromatic substitution of 7-bromo-1-
methyl-2-phenyl-1H-indole with NCTS (N-cyano-N-phenyl-p-toluenesulfonamide). The structural
identity of the title compound was proven by elemental analysis and spectroscopic methods (IR, NMR,
APCI-MS). Purity was assessed by two independent HPLC methods.
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1. Introduction
In recent years, inhibitors of tumor-related protein kinases were established as major therapeutic
options for the treatment of various human cancers [1,2]. In the context of our studies directed to
identify new protein kinase inhibitors based on the indole structure [3–7], we were interested in the
synthesis of the title compound 7-bromo-1-methyl-2-phenyl-1H-indole 3-carbonitrile (3).
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Scheme 1. Synthesis of 7-bromo-1-methyl-2-phenyl-1H-indole-3-carbonitrile (3) with 
N-cyano-N-phenyl-p-toluenesulfonamide (NCTS) (2). Reagents and conditions: i) BF3·OEt2, 
1,2-dichloroethane, closed vessel, bath temperature: 100 °C, 24 h. 
2. Results and Discussion 
The preparation of the starting material 1 was accomplished employing methods published in 
the literature [8,9]. The cyanation of indoles in the 3 position has been described earlier by the use of 
chlorosulfonyl isocyanate [10]. However, our attempt to apply this reaction to the starting 
compound 1 failed, leading only to traces of the desired product 3. We therefore used NCTS 
(N-cyano-N-phenyl-p-toluenesulfonamide) (2) [11] as an alternative reagent for the introduction of 
the nitrile group by electrophilic aromatic substitution [12] (Scheme 1). This reaction is carried out by 
heating the reagents in 1,2-dichloroethane in a closed vessel. Boron trifluoride diethyl etherate as a 
Lewis acid catalyzes the reaction by activating the cyanating reagent NCTS. The nitrile group acts as 
Scheme 1. Synthesis of 7-bromo-1-methyl-2-phenyl-1H-indole-3-carbonitrile (3) with N-cyano-N-
phenyl-p-toluenesulf namide (NCTS) (2). Reagents and conditions: i) BF3·OEt2, 1,2-dichloroethane,
closed vessel, bath temperature: 100 ◦C, 24 h.
2. Results and Discussion
The preparation of the starting material 1 was accomplished employing methods published
in the literature [8,9]. The cyanation f in oles in the 3 position has been described earlier by the
use of chlorosulfonyl isocyanate [10]. However, our attempt to apply this reaction to the starting
compound 1 failed, leading only to traces of the desired product 3. We therefore used NCTS
(N-cyano-N-phenyl-p-toluenesulfonamide) (2) [11] as an alternative reagent for the introduction of
the nitrile group by electrophilic aromatic substitution [12] (Scheme 1). This reaction is carried out
by heating the reagents in 1,2-dichloroethane in a closed vessel. Boron trifluoride diethyl etherate as
a Lewis acid catalyzes the reaction by activating the cyanating reagent NCTS. The nitrile group acts as
an electrophile and is transferred to position 3 of the indole. This method furnished the title compound
with high regioselectivity in moderate yield. The crude product which was obtained after work-up
was purified by crystallization from methanol.
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Purity was assessed by two independent HPLC methods (isocratic and gradient) and proved to
be sufficient for biological studies (>95%). The IR spectrum displayed the characteristic absorption
maximum for the C≡N stretching vibration (2212 cm−1).
3. Materials and Methods
3.1. Materials
The reagents and solvents were purchased from Acros Organics, Geel, Belgium. The reagents were
used without further purification. 1,2-Dichloroethane was purchased in extra dry quality. Purified
water was used for sodium hydroxide solution and dilute hydrochloric acid as well as for washing.
For HPLC analysis reagents of proper quality were used.
3.2. Instrumentation
The melting points were detected in open-glass capillaries on an electric variable heater
(Electrothermal IA 9100, Bibby Scientific, Stone, UK). The infrared spectra were recorded on a Thermo
Nicolet FT-IR 200 spectrometer (Thermo Nicolet, Madison, WI, USA) using KBr pellets. The 13C-NMR
and the 1H-NMR spectra were recorded on a Bruker Avance AV II-600 spectrometer (Bruker
Corporation, Billerica, MA, USA) (at the NMR Laboratories of the Chemical Institutes of the Technische
Universität Braunschweig) in DMSO-d6. Chemical shifts are presented in relation to TMS (δ = 0 ppm).
C nuclei were assigned based on results of 13C-DEPT135 experiments. HPLC was performed on
a VWR Hitachi Chromaster system (Hitachi High Technologies Corporation, Tokyo, Japan) (DAD
detector: 5430; column oven: 5310; pump: 5110; autosampler: 5260; column: Merck LiChroCART 125-4,
LiChrospher 100 RP-18 (5 µm) (Merck, Darmstadt, Germany); isocratic eluent: acetonitrile/water
mixture 70:30; gradient elution: concentration acetonitrile 0–2 min: 10%; 2–12 min: 10%→ 90% (linear)
12–20 min: 90%; elution rate: 1.000 mL/min; detection wavelength: 254 nm and 280 nm (isocratic),
254 nm (gradient); overall run time: 15 min (isocratic), 20 min (gradient); ts = dead time; tms = total
retention time). For mass spectrometry an expressionL CMS spectrometer was used with APCI source
coupled with ASAP (atmospheric solids analysis probe) (Advion, Ltd., Harlow, UK). The elemental
analysis was performed on a CE Instruments Flash EA® 1112 Elemental Analyzer (Thermo Quest, San
Jose, CA, USA). TLC: Polygram SIL G/UV254, 0.2 mm thickness (Macherey-Nagel, Düren, Germany).
3.3. Synthesis
7-Bromo-1-methyl-2-phenyl-1H-indole (121 mg, 0.423 mmol) (2) and NCTS (115 mg, 0.423 mmol)
(3) were dissolved in 1,2-dichloroethane (1 mL) in an argon flushed reaction vessel and boron trifluoride
diethyl etherate (200 µL, 1.58 mmol) was added. The solution was stirred in a closed vessel for 24 h in
a bath heated to 100 ◦C. After dilution with 1,2-dichloroethane (10 mL), the solution was washed with
aqueous sodium hydroxide (85 g/L), hydrochloric acid (73 g/L) and water (5 mL each) successively.
Evaporation of the organic phase gave a greenish solid substance. The crude product was purified by
dissolving in boiling methanol (12 mL) and crystallized by cooling the mixture to 2 ◦C and filtering the
solids, yielding greenish needles (54 mg, 41%).
M.p.: 176–178 ◦C; TLC (petrol ether/ethyl acetate 4:1): Rf = 0.41; 1H-NMR (600 MHz, DMSO-d6): δ
(ppm) = 4.02 (s, 3H, CH3), 7.23 (t, 1H, J = 7.9 Hz, C(5)H), 7.61 (dd, 1H, J = 7.7/1.0 Hz, ArH), 7.62–7.70
(m, 6H, ArH); 13C-NMR (151 MHz, DMSO-d6): δ (ppm) = 35.3 (CH3), 118.4, 123.8, 129.0 (2C), 129.1,
130.1 (2C), 130.4 (CH), 85.0, 104.6, 115.5, 128.0, 129.7, 132.9, 150.2 (C); IR (KBr) (cm−1): 2212 (C≡N),
1556 (ar C=C), 1479, 1463, 1440, 1413, 1393, 1353, 1296, 1201, 1130, 1064, 812, 784, 700; MS (APCI.
rel. intensity) m/z (%): 311 ([M + H]+, 100%); HPLC (AUC%): 99.34% at 254 nm, 99.65% at 280 nm,
tms = 4.66 min, ts (DMSO) = 1.27 min (isocratic); 98.70% at 254 nm, tms = 13.27 min, ts (DMSO) = 1.22 min
(gradient); Anal. calculated for C16H11BrN2 (311.18): C, 61.76; H, 3.56; N, 9.00. Found: C, 61.79; H, 3.47;
N, 8.87. 1H- and 13C-NMR spectra are reported in the supplementary materials as Figures S1 and S2.
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Supplementary Materials: The following are available, Figure S1: 1H-NMR spectrum of 3, Figure S2: 13C-NMR
spectrum of 3.
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Anal. elemental analysis
APCI-MS atmospheric pressure chemical ionisation mass spectrometry
HPLC high performance liquid chromatography
IR infrared spectrometry
NMR nuclear magnetic resonance
TLC thin layer chromatography
TMS tetramethylsilane
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